techMARK (TASX)

5,790.05
   
  • Change Today:
      5.13
  • 52 Week High: 5,804.58
  • 52 Week Low: 4,135.10

Latest ShareCast News

GSK chronic hepatitis B treatment hits goal in two studies

By Frank Prenesti

Date: Wednesday 07 Jan 2026

(Sharecast News) - GSK on Wednesday said its potential chronic hepatitis B treatment had met primary endpoints in two trials that covered 1,800 patients from 29 countries.

techMARK Regulatory News

EC approval of Shingrix PFS 07-Jan-2026 07:05 RNS
Positive phase 3 data for GSK's bepirovirsen 07-Jan-2026 07:00 RNS
Transaction in Own Shares 07-Jan-2026 07:00 RNS
Transaction in Own Shares 07-Jan-2026 07:00 RNS
XP Power Ltd - Notification of Q4 and Full Year ... 07-Jan-2026 07:00 PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Price Data

Price 5,790.05
Change Today 5.13
% Change 0.09 %
06-Jan-26 Close 5,784.92

Top Risers

Price Change
VOD 103.45p +2.9%
OXB 711.00p +2.0%
RSW 3,665.00p +1.1%
BA. 1,900.50p +1.0%
GNS 2,595.00p +0.8%
SGE 1,070.00p +0.4%
QQ. 480.80p +0.3%
OXIG 2,155.00p +0.0%
RM. 114.00p +0.0%
DIA 352.00p +0.0%

Top Fallers

Price Change
FLTR 16,100.00p -3.0%
GSK 1,878.50p -1.1%
TRD 247.27p -1.1%
APTD 297.00p -1.0%
NCC 132.60p -0.9%
CCC 3,028.00p -0.5%
SN. 1,252.00p -0.3%
BT.A 181.20p -0.2%
XPP 902.00p -0.0%
XAR 109.50p -0.0%

Top of Page